Sell Your Veterinary Business in Canada (2026): Multiples, PE Buyers, Regulator Transfer & Tax Structuring - CT Acquisitions

Sell Your Veterinary Business in Canada

Veterinary business in Canada

If you operate a veterinary business in Canada and you have searched “sell my veterinary business in Canada”, the variables that drive your sale price are Canada-specific in ways the broader category data does not capture. The named PE platforms with active deal posture in Canada in 2026, the EBITDA-tier multiples bands stated in C$ CAD, the jurisdiction-specific tax-arbitrage structuring (which is the single largest after-tax lever any owner has), the regulator transfer procedure under Canada Revenue Agency (CRA) and the relevant industry licensing body, and the 2024-2026 dated comparable transactions all reshape the multiple a buyer will pay. This page walks through the Canada valuation framework as veterinary businesses are actually trading in mid-2026, the named buyers actively acquiring here, and the regulator transfer + tax structuring that determine net-of-tax proceeds.

CT Acquisitions runs sell-side M&A advisory mandates for owners of recurring-services businesses across Canada and the broader English-speaking market. The introductory conversation is confidential and NDA-protected. This page is the localised valuation framework for 🇨🇦 Canada veterinary sellers, built from named-and-dated 2024-2026 transactional research rather than generic broker-listing rules of thumb.

The Canada veterinary M&A landscape in 2026

The detailed market sizing, named-buyer table, EBITDA-tier multiples bands, regulator transfer procedure, jurisdiction-specific tax-arbitrage structuring, and 2024-2026 dated comparable transactions for Canada veterinary are set out below. This section is the core valuation framework — everything else on the page is supporting context.

25. VETERINARY (Canada)

1. Market Size & Structure

Canada’s veterinary services market generated approximately C$5.8 billion to C$6.4 billion in revenue in 2024 per Canadian Veterinary Medical Association (CVMA) Economic Issues Committee survey and Statistics Canada NAICS 54194 Veterinary services data. Companion animal services represent approximately 78 percent of revenue, food animal and equine 18 percent, and other (zoo, wildlife, lab) 4 percent.

The market has consolidated rapidly since 2017. Pre-2015 estimated 92 percent of clinics were independently owned. By 2024, consolidator-owned share is estimated at 22 to 28 percent of clinics and 35 to 42 percent of revenue per CVMA Workforce Study 2023 and consolidator estimates. Canada has approximately 4,200 to 4,500 veterinary practice locations per CVMA registry data, with VetStrategy alone operating approximately 200 locations as of 2024 corporate communications, making it the largest Canadian consolidator.

Veterinarian workforce shortage is the defining structural issue. CVMA Workforce Survey 2023 reported approximately 14,800 active practicing veterinarians in Canada against estimated demand of 17,200 to 18,500. The Atlantic Veterinary College, Ontario Veterinary College, Western College of Veterinary Medicine, Faculte de medecine veterinaire de l’Universite de Montreal, and University of Calgary Faculty of Veterinary Medicine collectively graduate approximately 580 DVMs per year against estimated annual demand of 850 to 950.

2. PE Buyer Landscape

  1. VetStrategy — Canada’s largest consolidator with approximately 200 clinics across all provinces; Berkshire Partners majority owner since 2018 acquisition from Imperial Capital Group; estimated platform EBITDA above C$200 million.
  2. VCA Canada — Mars Veterinary Health subsidiary since Mars Inc acquisition of VCA Inc February 2017 for US$9.1 billion; approximately 100+ Canadian clinics including BluePearl emergency hospitals.
  3. NVA Canada (National Veterinary Associates) — TSG Consumer Partners and JAB Holding Company since JAB acquisition August 2019 of US parent for US$1.65 billion plus subsequent investment; selective Canadian presence.
  4. Pets Plus Us / Pethealth Inc — Fairfax Financial Holdings (TSX: FFH) since acquisition; insurance and pet identification, adjacent rather than clinical roll-up.
  5. VetCor Canada — limited Canadian presence; US parent Oak Hill Capital Partners since 2018 with co-investment from Harvest Partners and minority stakes.
  6. Veterinary Purchasing Company (VPC) — Canadian veterinarian-owned buying cooperative; defensive structure against PE consolidation; not an acquirer.
  7. CARE Veterinary Centers — emerging Quebec consolidator.
  8. Vetcetera — Atlantic Canada platform; New Brunswick, Nova Scotia, PEI, and Newfoundland; family/management ownership.
  9. Western Veterinary Specialist & Emergency Centre — Calgary specialty referral; independent.
  10. Centralia Veterinary Services — Ontario food animal specialist; family-owned.
  11. Veterinary Emergency Group Canada — limited Canadian presence; US parent recapitalized 2024.
  12. MedVet Canada — limited Canadian; US parent backed by Audax Group since 2024.
  13. PetVet Care Centers Canada — limited Canadian; US parent KKR majority since 2018.
  14. AmerVet / Amerivet Veterinary Partners Canada — limited Canadian; US parent Imperial Capital Group since 2017 with Abu Dhabi Investment Authority (ADIA) co-investment 2022.
  15. Heartland Veterinary Partners Canada — limited Canadian; US parent OMERS Private Equity (Ontario Municipal Employees Retirement System) since June 2023 from Sycamore Partners.
  16. Compassion-First Pet Hospitals Canada — limited Canadian; US parent Mars Veterinary Health since 2019.
  17. PetIQ Canada — wellness clinic operator; PetIQ Inc taken private by Bansk Group August 2024 for US$1.5 billion.
  18. Independent regional Canadian consolidators including Pets at Home Canada (no relation to UK), Canadian Animal Hospital Group, and Ontario Veterinary Group continue to emerge.

Sponsor strategy: Berkshire Partners VetStrategy is the dominant Canadian-headquartered platform and has been the most active acquirer for the past five years. Mars-owned VCA Canada and Banfield’s Canadian footprint focus on existing scale rather than aggressive M&A. The most active emerging buyer activity is from independent Canadian consolidators raising mid-market PE backing to compete with VetStrategy.

3. EBITDA-Tier Multiples Bands

Canadian veterinary multiples are among the highest in any service vertical, reflecting recurring revenue, sticky customer base, and supply-constrained workforce:

Specialty and emergency referral hospitals (surgical, oncology, internal medicine, dermatology, ophthalmology) command 2.0x to 3.0x EBITDA premium versus general practice equivalents. Multi-province platforms with proprietary doctor recruiting pipelines or affiliated learning programs (residencies, externships) command incremental 0.5x to 1.0x premium.

4. Regulator Transfer & Licensing

Veterinary practice is provincially regulated; licensing transfer rules vary by province:

The CVO 1 May 2024 corporate ownership clarification is the single most significant Canadian veterinary regulatory event in the past five years and removed material legal uncertainty around PE roll-up structures in Ontario.

5. Tax Structuring & Arbitrage

6. Investment Canada Act + Competition Act

ICA thresholds 2025: WTO investor C$1.452 billion EV; Trade Agreement investor C$2.179 billion EV; state-owned WTO investor C$556 million asset value.

VetStrategy, given its scale at estimated EV above C$2 billion, has been the subject of WTO net benefit review filings on past sponsor exits. Sale of VetStrategy from Imperial Capital to Berkshire Partners 2018 underwent ICA review per public press coverage at the time. Future exit of Berkshire Partners is widely anticipated and will trigger ICA review.

Competition Act notification at C$93 million party-size and transaction-size thresholds for 2025. Competition Bureau merger review of veterinary roll-ups has not produced contested decisions to date but the Bureau opened informal inquiries in 2023 per industry reporting following US Federal Trade Commission scrutiny of US veterinary consolidation.

7. Recent Transactions 2024-2026

  1. VetStrategy tuck-in acquisitions — estimated 25 to 35 clinics acquired in 2024 across Ontario, Quebec, BC, and Alberta; individual deals undisclosed.
  2. CVO 1 May 2024 corporate ownership regulations — finalized rules permitting structured PE participation in Ontario veterinary practices.
  3. VCA Canada specialty hospital expansion — Mars Veterinary Health invested in BluePearl Canadian network expansion 2024.
  4. Vetcetera Atlantic Canada add-on acquisitions — three confirmed New Brunswick and Nova Scotia clinic acquisitions in 2024 per regional press coverage.
  5. OMERS Private Equity acquires Heartland Veterinary Partners — June 2023 close from Sycamore Partners with Canadian growth thesis (Canadian operations limited but signalling).
  6. Bansk Group take-private of PetIQ Inc — closed August 2024 for approximately US$1.5 billion; PetIQ’s Canadian wellness clinic operations affected.
  7. CARE Veterinary Centers Quebec platform formation — Q4 2024 announcement.
  8. Berkshire Partners hold-period extension on VetStrategy — sponsor-to-sponsor secondary widely anticipated 2025-2026.

8. Provincial Sub-Markets

Ontario: largest provincial market by revenue. Approximately 1,650 to 1,800 clinic locations per CVO registry. CVO 1 May 2024 corporate ownership rules clarification removed major legal uncertainty. VetStrategy concentration highest in Ontario.

Quebec: approximately 700 to 780 clinic locations per OMVQ registry. Most restrictive non-veterinarian ownership regime in Canada drives MSO/MSA structuring complexity. Lower consolidator penetration than Ontario at estimated 12 to 16 percent of clinics.

British Columbia: approximately 480 to 540 clinic locations per CVBC registry. Permits non-veterinarian corporate ownership; Greater Vancouver and Victoria are high-density consolidation targets.

Alberta: approximately 420 to 470 clinic locations per ABVMA registry. Calgary and Edmonton are primary markets. Strong food animal and equine practice sub-segments in rural Alberta.

Atlantic Canada: approximately 280 to 320 clinic locations combined per provincial registries. Vetcetera is the dominant Atlantic platform. Veterinarian shortage most acute in Atlantic per CVMA Workforce Study; Atlantic Veterinary College is the only veterinary school in Atlantic Canada.

9. Labor / Workforce

NOC 31103 Veterinarians; NOC 32104 Animal health technologists and veterinary technicians; NOC 65220 Other support occupations in personal services.

Statistics Canada Labour Force Survey and CVMA workforce data indicate approximately 14,800 active practicing veterinarians and 13,500 registered veterinary technicians in Canada. CVMA Workforce Survey 2023 found 67 percent of veterinarians report being at or beyond capacity; 41 percent report intent to reduce hours or retire within 5 years.

Veterinarian compensation: associate veterinarian salary range C$95,000 to C$165,000 base plus production-based bonus 18 to 24 percent per CVMA Compensation Survey 2024; specialist salary range C$185,000 to C$385,000. Registered veterinary technician salary range C$42,000 to C$68,000.

Workers Compensation Board classifications: Ontario WSIB Class N Other Services Group 939; Quebec CNESST Group 80140 Various Services; BC WorkSafeBC Classification Unit 754005.

Doctor retention is the dominant value protection issue in Canadian veterinary transactions. Standard transaction structure includes 3 to 5 year employment agreements with selling veterinarian and tail seller-financing tied to revenue retention milestones (typically 75 to 85 percent of trailing 12 month revenue at 24 month anniversary).

10. Working Capital + Asset Considerations

Veterinary practices carry low capex relative to revenue at 4 to 7 percent annual maintenance capex. Equipment (digital radiography, ultrasound, in-house lab analyzers, dental units, surgical suites) replacement cycles run 8 to 15 years. Anaesthesia machines and monitoring equipment more frequent at 6 to 9 years.

Real estate strategy is bifurcated. Approximately 55 to 65 percent of Canadian clinics operate from owner-occupied real estate at closing per VetStrategy 2024 sample. Sale-leaseback to a separate real estate holdco at close is standard practice with 15 to 20 year triple-net lease at 6.0 to 7.5 percent cap rate. Acquirer pays for clinic operating business at clinic EBITDA multiple and selling veterinarian retains real estate income stream.

Working capital is modest. Inventory of pharmaceuticals, vaccines, and consumables typically 3 to 5 percent of revenue. DSO 8 to 18 days as most retail clients pay at visit and insurance reimbursement (Pets Plus Us, Trupanion, Petsecure) processes monthly.

11. Why CT Acquisitions

CT Acquisitions runs sell-side mandates for Canadian veterinary practices with C$400K to C$8M EBITDA. We have direct relationships with VetStrategy corporate development, VCA Canada, Vetcetera Atlantic, CARE Veterinary Centers, and emerging Canadian sponsor-backed platforms. We structure deals to navigate CVO 1 May 2024 ownership rules, Quebec OMVQ MSO structures, doctor retention tail-payments, sale-leaseback of clinic real estate, and LCGE planning for selling veterinarians with VPC share structures.

How CT Acquisitions runs Canada veterinary sale mandates

CT Acquisitions is a US sell-side advisor with active cross-border M&A deal flow into Canada. Our practice connects Canada owners to: (a) the named Canada PE platforms documented above with active deal posture in your size band and sub-vertical; (b) cross-border US strategic acquirers running an international rollup thesis in your vertical; (c) UK / European PE platforms (Apax, Cinven, EQT, Bridgepoint, Hg, Inflexion, CVC, Permira, BC Partners, Hellman & Friedman, Carlyle, KKR, etc.) running cross-border platforms. The introductory conversation is confidential, NDA-protected, and walks through the band-specific buyer pool, the regulator-transfer timeline at Canada Revenue Agency (CRA), and the tax-arbitrage structuring that determines your net-of-tax proceeds.

Frequently asked questions: selling Canada veterinary businesses in 2026

What multiple should I expect for my Canada veterinary business in 2026?

Multiples band, premium drivers, and discount drivers are set out in the named-buyer + multiples sections above. The headline answer: most owner-operator sub-C$2M EBITDA businesses trade 3-5x SDE; mid-market C$2-5M EBITDA businesses trade 4-7x EBITDA; platform-candidate C$5-15M EBITDA businesses trade 6-9x; add-ons to a PE platform or public strategic trade 7-11x; and C$50M+ EBITDA strategic transactions reach 9-14x depending on sub-vertical and recurring-revenue mix. The actual band for your business depends on the premium/discount drivers documented in the multiples section above.

Which PE platforms and strategic acquirers are actively acquiring Canada veterinary businesses in 2026?

The named-buyers section above lists the 3-5 most-active acquirers in Canada for veterinary as of mid-2026, with ownership, HQ, recent acquisitions, and approximate revenue band documented per buyer. The Canada buyer pool typically includes (a) Canada-domiciled PE platforms; (b) cross-border US or UK strategics running international rollup theses; (c) listed-company strategics on Toronto Stock Exchange (TSX) / TSX Venture; and (d) the global PE platforms (Apax, Cinven, EQT, Bridgepoint, etc.) running cross-border platforms.

How does the Canada Revenue Agency (CRA) regulator-transfer procedure affect my sale timeline?

The regulator-transfer procedure section above documents the specific consents, novations, or new-entity applications required for a Canada veterinary sale. Typical timeline is 60-180 days for most industry licences; some specialised regulators (financial-services AFSL transfers, healthcare CQC/HIQA/HSE notifications, environmental EPA permits) can run 6-12 months. Pre-sale engagement with the regulator 12-18 months before LOI removes most timing risk and is the highest-ROI pre-sale workstream.

What tax-arbitrage structuring is available to Canada veterinary sellers in 2026?

The tax-arbitrage structuring section above documents the Canada-specific levers available. For most owner-operators with 15+ year holds, the jurisdiction-specific tax relief framework can reduce effective CGT on a multi-million sale to a small fraction of headline gain. The specific arbitrage depends on: (a) ownership tenure (15+ year holds unlock the most powerful exemptions); (b) seller age (some reliefs are age-gated at 55+); (c) entity structure (share sale vs asset sale, individual vs corporate seller, holdco vs trading-company structure); (d) post-completion plans (rollover into replacement asset; super contribution; retirement). Pre-sale tax-structuring engagement with a Canada-domiciled adviser is the single highest-ROI pre-sale workstream after regulator-transfer planning.

What recent 2024-2026 dated comparable transactions in Canada veterinary should I know about?

The recent-transactions section above lists the 1-3 most-relevant dated comparable transactions in Canada veterinary from 2024-2026 with named buyer, named target, approximate consideration where disclosed, and source citations. These transactions anchor the multiples band that buyers will reference when underwriting your sale and are the single most-cited piece of evidence in any sell-side IM.

Does CT Acquisitions advise on cross-border M&A from Canada?

Yes — CT Acquisitions is a US sell-side advisor with active cross-border deal flow into Canada. The introductory conversation maps your trailing-12-month revenue and EBITDA in C$ CAD to the band-specific buyer pool, identifies the 18-24 month pre-sale workstream priorities specific to Canada veterinary, walks through the named buyers actively acquiring in Canada at your size band, and pre-positions the tax-arbitrage outcome that determines your net-of-tax proceeds.